Preliminary observations of passive exercise using whole body periodic acceleration on coronary microcirculation and glucose tolerance in patients with type 2 diabetes

Journal of Cardiology

Volumn 60, Issue 4, 2012, Pages 283-287

  Sakaguchi, Mikumo ^a   Fukuda, Shota ^b   Shimada, Kenei ^a   Izumi, Yasukatsu ^a   Izumiya, Yasuhiro ^c   Nakamura, Yasuhiro ^a   Nakanishi, Koki ^a   Otsuka, Kenichiro ^a   Ogawa, Hisao ^c   Fujita, Masatoshi ^d   Yoshikawa, Junichi ^e   Yoshiyama, Minoru ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Ekisaikai Hospital   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Nishinomiya Watanabe Cardiovascular Center   (Japan)

Author keywords

Coronary microcirculation; Diabetes mellitus; Exercise; Transthoracic echocardiography

Indexed keywords

ADENOSINE; ADIPONECTIN; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; FLOW RATE; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; WHOLE BODY PERIODIC ACCELERATION;

ACCELERATION; ADIPONECTIN; AGED; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE THERAPY; HUMANS; INSULIN; MALE; MICROCIRCULATION;

EID: 84866545759     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.05.006     Document Type: Article

References (32)

1. Pedersen B.K., Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006, 16(Suppl. 1):3-63.
2. Warburton D.E., Nicol C.W., Bredin S.S. Health benefits of physical activity: the evidence. Can Med Assoc J 2006, 174:801-809.
3. Yamagishi S. Cardiovascular disease in recent onset diabetes mellitus. J Cardiol 2011, 57:257-262.
4. Uemura Y., Watarai M., Ishii H., Koyasu M., Takemoto K., Yoshikawa D., Shibata R., Matsubara T., Murohara T. Atorvastatin 10mg plus ezetimibe 10mg compared with atorvastatin 20mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease. J Cardiol 2012, 59:50-56.
5. Nelson M.E., Rejeski W.J., Blair S.N., Duncan P.W., Judge J.O., King A.C., Macera C.A., Castaneda-Sceppa C. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116:1094-1105.
6. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M.L., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
7. Lara-Castro C., Luo N., Wallace P., Klein R.L., Garvey W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55:249-259.
8. Ajuwon K.M., Spurlock M.E. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1220-R1225.
9. Fisher F.M., Trujillo M.E., Hanif W., Barnett A.H., McTernan P.G., Scherer P.E., Kumar S. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 2005, 48:1084-1087.
10. Hara K., Horikoshi M., Yamauchi T., Yago H., Miyazaki O., Ebinuma H., Imai Y., Nagai R., Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29:1357-1362.
11. Sigal R.J., Kenny G.P., Wasserman D.H., Castaneda-Sceppa C. Physical activity/exercise and type 2 diabetes. Diabetes Care 2004, 27:2518-2539.
12. Kohler M., Amann-Vesti B.R., Clarenbach C.F., Brack T., Noll G., Russi E.W., Bloch K.E. Periodic whole body acceleration: a novel therapy for cardiovascular disease. VASA 2007, 36:261-266.
13. Sackner M.A., Gummels E., Adams J.A. Nitric oxide is released into circulation with whole-body, periodic acceleration. Chest 2005, 127:30-39.
14. Uryash A., Wu H., Bassuk J., Kurlansky P., Sackner M.A., Adams J.A. Low-amplitude pulses to the circulation through periodic acceleration induces endothelial-dependent vasodilatation. J Appl Physiol 2009, 106:1840-1847.
15. Adams J.A., Wu H., Bassuk J.A., Arias J., Uryash A., Kurlansky P. Periodic acceleration (pGz) acutely increases endothelial and neuronal nitric oxide synthase expression in endomyocardium of normal swine. Peptides 2009, 30:373-377.
16. Fukuda S., Shimada K., Kawasaki T., Kono Y., Jissho S., Taguchi H., Maeda K., Yoshiyama M., Fujita M., Yoshikawa J. "Passive exercise" using whole body periodic acceleration: effects on coronary microcirculation. Am Heart J 2010, 159:620-626.
17. Matsumoto T., Fujita M., Tarutani Y., Yamane T., Takashima H., Nakae I., Horie M. Whole-body periodic acceleration enhances brachial endothelial function. Circ J 2008, 72:139-143.
18. Rokutanda T., Izumiya Y., Miura M., Fukuda S., Shimada K., Izumi Y., Nakamura Y., Araki S., Hanatani S., Matsubara J., Nakamura T., Kataoka K., Yasuda O., Kaikita K., Sugiyama S., et al. Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb. Arterioscler Thromb Vasc Biol 2011, 31:2872-2880.
19. Nishimura A., Sawai T. Determination of adiponectin in serum using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer. Clin Chim Acta 2006, 371:163-168.
20. Nakano Y., Tajima S., Yoshimi A., Akiyama H., Tsushima M., Tanioka T., Negoro T., Tomita M., Tobe T. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 2006, 47:1572-1582.
21. Figoni S.F., Rodgers M.M., Glaser R.M., Hooker S.P., Feghri P.D., Ezenwa B.N., Mathews T., Suryaprasad A.G., Gupta S.C. Physiologic responses of paraplegics and quadriplegics to passive and active leg cycle ergometry. J Am Paraplegia Soc 1990, 13:33-39.
22. Nash M.S., Bilsker M.S., Kearney H.M., Ramirez J.N., Applegate B., Green B.A. Effects of electrically stimulated exercise and passive motion on echocardiographically derived wall motion and cardiodynamic function in tetraplegic persons. Paraplegia 1995, 33:80-89.
23. Bell H.J., Ramsaroop D.M., Duffin J. The respiratory effects of two modes of passive exercise. Eur J Appl Physiol 2003, 88:544-552.
24. Smits P., Williams S.B., Lipson D.E., Banitt P., Rongen G.A., Creager M.A. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 1995, 92:2135-2141.
25. Hein T.W., Kuo L. cAMP-independent dilation of coronary arterioles to adenosine: role of nitric oxide, G proteins, and K(ATP) channels. Circ Res 1999, 85:634-642.
26. Anderson T.J. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999, 34:631-638.
27. Kraemer R.R., Castracane V.D. Exercise and humoral mediators of peripheral energy balance: ghrelin and adiponectin. Exp Biol Med (Maywood) 2007, 232:184-194.
28. Simpson K.A., Singh M.A. Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring) 2008, 16:241-256.
29. Murata E., Hozumi T., Matsumura Y., Fujimoto K., Sugioka K., Takemoto Y., Watanabe H., Yamagishi H., Yoshiyama M., Iwao H., Yoshikawa J. Coronary flow velocity reserve measurement in three major coronary arteries using transthoracic Doppler echocardiography. Echocardiography 2006, 23:279-286.
30. Reis S.E., Holubkov R., Lee J.S., Sharaf B., Reichek N., Rogers W.J., Walsh E.G., Fuisz A.R., Kerensky R., Detre K.M., Sopko G., Pepine C.J. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 1999, 33:1469-1475.
31. Serruys P.W., de Bruyne B., Carlier S., Sousa J.E., Piek J., Muramatsu T., Vrints C., Probst P., Seabra-Gomes R., Simpson I., Voudris V., Gurne O., Pijls N., Belardi J., van Es G.A., et al. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement. Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II study group. Circulation 2000, 102:2930-2937.
32. Di Mario C., Moses J.W., Anderson T.J., Bonan R., Muramatsu T., Jain A.C., Suarez de Lezo J., Cho S.Y., Kern M., Meredith I.T., Cohen D., Moussa I., Colombo A. Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler. DESTINI study group (Doppler Endpoint STenting INternational Investigation). Circulation 2000, 102:2938-2944.